SpyGlass Pharma SGP Income Statement (2024-2026)

NASDAQ SGP
$26.09 -0.07 (-0.27%)
As of: Oct 21, 2026 · 10:09 AM EDT
Reported Financials

SpyGlass Pharma Quarterly Income Statement

Periods 4 quarters
Latest Jun 2026

SpyGlass Pharma reported net income of -$19.86M for the quarter ended Jun 2026. This income statement covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Research & DevelopmentR&D 7.33M10.94M
Selling, General & AdministrativeSG&A 1.96M11.03M
Operating ExpensesOpex 9.30M21.97M
Operating IncomeOp. Inc -9.30M-21.97M
EBIT -9.30M-21.97M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 0.62M2.10M
Non Operating IncomeNon Op. Inc. 0.62M2.10M
Net income details
EBT -8.68M-19.86M
Profit After TaxPAT -8.68M-19.86M
Income from Continuing OperationsIncome (Continuing) -8.68M-19.86M
Consolidated Net IncomeConsol Net Inc. -8.68M-19.86M
Income towards Parent CompanyParent Net Inc -8.68M-19.86M
Net Income towards Common StockholdersNet Income -8.68M-19.86M
Additional items
EPS (Basic) -3.81-0.59
EPS (Diluted) -3.81-0.59
Shares Outstanding 1.79M2.28M2.22M33.44M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.79M2.28M2.22M33.44M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.79M2.12M2.20M33.45M
EBITDA -9.16M-21.63M

SpyGlass Pharma Income Statement API

Pull SpyGlass Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY